Pharmaceutical nanotechnology stands at the forefront of scientific innovation, merging nanoscience and technology to reshape drug development and healthcare interventions. Operating at the nanoscale, it exploits distinctive material properties to finely tune drug formulations, enhancing effectiveness while minimizing adverse effects. This interdisciplinary field not only addresses conventional pharmaceutical challenges but also opens novel avenues for advancements.
Pharmaceutical nanotechnology has also paved the way for personalized medicine. By tailoring drug formulations at the nanoscale, healthcare professionals can optimize treatment regimens based on individual patient characteristics. This level of customization holds great promise for more effective and patient-specific therapies.
Moreover, the diagnostic capabilities of pharmaceutical nanotechnology are remarkable. Nanoscale imaging agents and sensors enable early detection of diseases at the molecular level, allowing for timely interventions and monitoring of treatment responses. This integration of diagnostics and therapeutics is a hallmark of the nanotechnology revolution in pharmaceuticals. As research in this field progresses, addressing these challenges will be crucial to fully realize the potential of nanotechnology in transforming healthcare and pharmaceutical industries.
Pharmaceutical nanotechnology offers a diverse range of applications that redefine drug development, delivery, and diagnostic processes. Some notable applications include:
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia